ELASE ONT 666 UNIT
DEOXYRIBONUCLEASE PANCREATIC : 666 UNIT FIBRINOLYSIN : 1 UNIT · DIN 00024082 · PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is ELASE ONT?
ELASE ONT 666 UNIT contains DEOXYRIBONUCLEASE PANCREATIC : 666 UNIT FIBRINOLYSIN : 1 UNIT. It is listed in the Health Canada Drug Product Database under DIN 00024082, held by PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC., supplied as OINTMENT for TOPICAL ; VAGINAL administration. Health Canada currently lists it as cancelled post market, status dated 07-Apr-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00024082 |
|---|---|
| Brand name | ELASE ONT |
| Generic / active ingredient | DEOXYRIBONUCLEASE PANCREATIC : 666 UNIT FIBRINOLYSIN : 1 UNIT |
| Manufacturer | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. |
| Strength | 666 UNIT |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL ; VAGINAL |
| Schedule | Ethical |
| ATC code | D03BA PROTEOLYTIC ENZYMES |
| AHFS class | 08:12.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 07-Apr-1998 |
| Original market date | 1969-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D03BA PROTEOLYTIC ENZYMES. 0 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ELASE CHLOROMYCETIN ONT | 1 UNIT | OINTMENT | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | DIN 00156124 |
| TRAVASE OINTMENT 82000 CASEIN UNITS/GM | 82000 UNIT | OINTMENT | BOOTS PHARMACEUTICALS INC. | CANCELLED POST MARKET | DIN 02034476 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.